MCK:NYE-McKesson Corporation (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 597.45

Change

+7.50 (+1.27)%

Market Cap

USD 31.54B

Volume

0.53M

Analyst Target

USD 185.31
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. Its segments include McKesson Distribution Solutions and McKesson Technology Solutions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-17 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

+0.45 (+0.20%)

USD 44.41B
CAH Cardinal Health Inc

+0.41 (+0.38%)

USD 26.96B
NVG Nuveen AMT Free Municipal Cred..

+0.03 (+0.23%)

N/A
OMI Owens & Minor Inc

+1.20 (+8.26%)

N/A

ETFs Containing MCK

BGU-U:CA Bristol Gate Concentrated.. 5.05 % 0.00 %

N/A

CAD 0.11B
DBPD:XETRA Xtrackers ShortDAX x2 Dai.. 4.88 % 0.00 %

-0.03 (-0.22%)

USD 0.13B
BLOV:CA Brompton North American L.. 4.45 % 0.00 %

-0.11 (-0.22%)

CAD 0.01B
CFCV 4.16 % 0.00 %

N/A

N/A
XYLP:LSE Global X S&P 500® Covere.. 4.10 % 0.00 %

-0.03 (-0.22%)

N/A
WHCS:SW iShares MSCI World Health.. 3.15 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 3.08 % 0.00 %

-0.01 (-0.22%)

N/A
CBUF:XETRA iShares MSCI World Health.. 2.64 % 0.00 %

-0.01 (-0.22%)

USD 1.13B
POWA Invesco Bloomberg Pricing.. 2.11 % 0.00 %

+0.87 (+-0.22%)

N/A
BMVP Invesco Bloomberg MVP Mul.. 2.11 % 0.00 %

+0.13 (+-0.22%)

N/A
TDVG T. Rowe Price Dividend Gr.. 1.75 % 0.00 %

+0.11 (+-0.22%)

USD 0.70B
XLVE:CA Mulvihill U.S. Health Car.. 1.73 % 0.00 %

N/A

N/A
MVEW:XETRA iShares Edge MSCI World M.. 1.41 % 0.00 %

+0.01 (+-0.22%)

USD 0.78B
MVEC:SW iShares Edge MSCI World M.. 1.41 % 0.00 %

+0.02 (+-0.22%)

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.41 % 0.00 %

N/A

USD 0.62B
MVWE:SW iShares Edge MSCI World M.. 1.41 % 0.00 %

N/A

USD 0.07B
SXR0:F iShares VI Public Limited.. 1.28 % 0.00 %

+0.03 (+-0.22%)

N/A
SXR0:XETRA iShares Edge MSCI World M.. 1.28 % 0.00 %

+0.02 (+-0.22%)

USD 0.09B
UEEH:XETRA iShares Edge MSCI World M.. 1.28 % 0.00 %

+0.01 (+-0.22%)

USD 0.03B
MVOL:SW iShares Edge MSCI World M.. 1.28 % 0.00 %

+0.03 (+-0.22%)

USD 3.08B
MVSH:SW iShares Edge MSCI World M.. 1.28 % 0.00 %

+0.02 (+-0.22%)

USD 0.04B
XDEB:F db x-trackers MSCI World .. 1.28 % 0.00 %

+0.02 (+-0.22%)

USD 0.45B
XDEB:XETRA db x-trackers MSCI World .. 1.28 % 0.00 %

+0.01 (+-0.22%)

USD 0.42B
XDEB:SW Xtrackers MSCI World Mini.. 1.28 % 0.00 %

+0.20 (+-0.22%)

N/A
DEF 0.00 % 0.59 %

N/A

N/A
DEUS Xtrackers Russell US Mult.. 0.00 % 0.18 %

+0.47 (+-0.22%)

USD 0.17B
EZY 0.00 % 0.38 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
ONEO SPDR® Russell 1000 Momen.. 0.00 % 0.20 %

+0.96 (+-0.22%)

N/A
CLRG 0.00 % 0.25 %

N/A

N/A
BVNSC 0.00 % 0.00 %

N/A

N/A
BGU:CA Bristol Gate Concentrated.. 0.00 % 0.85 %

+0.43 (+-0.22%)

CAD 0.12B
RTH VanEck Retail ETF 0.00 % 0.35 %

+1.32 (+-0.22%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

+0.36 (+-0.22%)

N/A
RYH 0.00 % 0.40 %

N/A

N/A
SPYB 0.00 % 0.35 %

N/A

N/A
SYV 0.00 % 0.60 %

N/A

N/A
STPL:CA BMO Global Consumer Stapl.. 0.00 % 0.40 %

+0.14 (+-0.22%)

CAD 0.04B
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

-7.50 (-0.22%)

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.29 (+-0.22%)

N/A
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

-2.46 (-0.22%)

USD 0.14B
XDEB:LSE db x-trackers MSCI World .. 0.00 % 0.00 %

-4.00 (-0.22%)

N/A
IQQ0:F iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.04% 100% F 95% A
Dividend Return 0.27% 25% F 10% F
Total Return 29.31% 100% F 94% A
Trailing 12 Months  
Capital Gain 47.08% 100% F 94% A
Dividend Return 0.61% 25% F 6% D-
Total Return 47.69% 100% F 93% A
Trailing 5 Years  
Capital Gain 342.79% 80% B- 96% N/A
Dividend Return 7.60% 40% F 25% F
Total Return 350.39% 80% B- 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 36.50% 80% B- 92% A
Dividend Return 37.47% 80% B- 92% A
Total Return 0.97% 40% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 20.81% 60% D- 51% F
Risk Adjusted Return 180.01% 100% F 95% A
Market Capitalization 31.54B 100% F 97% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.90 40% 27%
Price/Book Ratio 5.04 67% 17%
Price / Cash Flow Ratio 17.82 25% 20%
Price/Free Cash Flow Ratio 16.75 25% 20%
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital 89.20% 100% 99%
Return on Assets 4.41% 100% 68%
Debt to Equity Ratio -283.05% 100% 97%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.